Immatics Biotechnologies Gmbh opposition analysis

COMPANY ANALYSIS

Latest patents of Immatics Biotechnologies Gmbh opposed by its competitors

Patent:
Grant Date:
Sep 7, 2022
Title:
Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other Cancers
Oppositions:
1

Competitors of Immatics Biotechnologies Gmbh

ADAPTIMMUNE LIMITED

Want to track Immatics Biotechnologies Gmbh?

Feel free to send us a message here and we will get back to you